Shashank Tummala

515 total citations
10 papers, 429 citations indexed

About

Shashank Tummala is a scholar working on Biomaterials, Molecular Biology and Oncology. According to data from OpenAlex, Shashank Tummala has authored 10 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomaterials, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Shashank Tummala's work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (3 papers) and Advancements in Transdermal Drug Delivery (2 papers). Shashank Tummala is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (3 papers) and Advancements in Transdermal Drug Delivery (2 papers). Shashank Tummala collaborates with scholars based in India and United States. Shashank Tummala's co-authors include M. N. Satish Kumar, Gowthamarajan Kuppusamy, Sai Kiran S. S. Pindiprolu, Veera Venkata Satyanarayana Reddy Karri, SubbaRao V. Madhunapantula, Ashish Wadhwani, Pavan Kumar Chintamaneni, Surendra Kumar, Karthik Yamjala and Praveen Thaggikuppe Krishnamurthy and has published in prestigious journals such as Drug Delivery, Artificial Cells Nanomedicine and Biotechnology and Saudi Pharmaceutical Journal.

In The Last Decade

Shashank Tummala

10 papers receiving 423 citations

Peers

Shashank Tummala
Shashank Tummala
Citations per year, relative to Shashank Tummala Shashank Tummala (= 1×) peers Gitu Pandey

Countries citing papers authored by Shashank Tummala

Since Specialization
Citations

This map shows the geographic impact of Shashank Tummala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shashank Tummala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shashank Tummala more than expected).

Fields of papers citing papers by Shashank Tummala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shashank Tummala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shashank Tummala. The network helps show where Shashank Tummala may publish in the future.

Co-authorship network of co-authors of Shashank Tummala

This figure shows the co-authorship network connecting the top 25 collaborators of Shashank Tummala. A scholar is included among the top collaborators of Shashank Tummala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shashank Tummala. Shashank Tummala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Pindiprolu, Sai Kiran S. S., et al.. (2017). RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies. Artificial Cells Nanomedicine and Biotechnology. 46(2). 387–397. 49 indexed citations
2.
Tummala, Shashank, Gowthamarajan Kuppusamy, & M. N. Satish Kumar. (2016). Oxaliplatin immunohybrid nanoparticles in vitro synergistic suppression evaluation in treatment of colorectal cancer. Artificial Cells Nanomedicine and Biotechnology. 45(2). 261–269. 5 indexed citations
3.
Tummala, Shashank, M. N. Satish Kumar, & Sai Kiran S. S. Pindiprolu. (2016). Improved anti-tumor activity of oxaliplatin by encapsulating in anti-DR5 targeted gold nanoparticles. Drug Delivery. 23(9). 3505–3519. 56 indexed citations
4.
Tummala, Shashank, Gowthamarajan Kuppusamy, M. N. Satish Kumar, & Ashish Wadhwani. (2015). Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors. Drug Delivery. 23(5). 1773–1787. 52 indexed citations
6.
Tummala, Shashank, Gowthamarajan Kuppusamy, M. N. Satish Kumar, Praveen Thaggikuppe Krishnamurthy, & Ashish Wadhwani. (2015). 5-Fluorouracil enteric-coated nanoparticles for improved apoptotic activity and therapeutic index in treating colorectal cancer. Drug Delivery. 23(8). 2902–2910. 13 indexed citations
7.
Kuppusamy, Gowthamarajan, et al.. (2015). Lipid-based nanocarriers for breast cancer treatment – comprehensive review. Drug Delivery. 23(4). 1291–1305. 84 indexed citations
8.
Tummala, Shashank, et al.. (2014). PREPARATION, PHYSICOCHEMICAL CHARACTERIZATION AND IN VITRO EVALUATION OF OXALIPLATIN SOLID LIPID NANOPARTICLES FOR THE TREATMENT OF COLORECTAL CANCER. Indo American Journal of Pharmaceutical Research. 4(8). 3579–3587. 8 indexed citations
9.
Raju, Kalidhindi Rama Satyanarayana, Saurabh Gupta, Vishakantha Murthy, et al.. (2014). 5-Aminosalicylic Acid attenuates allergen-induced airway inflammation and oxidative stress in asthma. Pulmonary Pharmacology & Therapeutics. 29(2). 209–216. 27 indexed citations
10.
Tummala, Shashank, et al.. (2014). Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer. Saudi Pharmaceutical Journal. 23(3). 308–314. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026